A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo-immunized patients.
Br J Haematol
; 189(3): 551-558, 2020 05.
Article
in En
| MEDLINE
| ID: mdl-32086819
Full text:
1
Database:
MEDLINE
Main subject:
Immunization
/
Platelet Transfusion
/
Antibodies, Monoclonal, Humanized
/
HLA Antigens
Type of study:
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2020
Type:
Article